Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

Harry D. Bear; Wen Wan; André Robidoux; Peter Rubin; Steven Limentani; Richard L. White; James Granfortuna; Judith O. Hopkins; Dwight Oldham; Angel Rodriguez; Amy P. Sing

doi:10.1002/jso.24798

Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Richard L. White, James Granfortuna, Judith O. Hopkins, Dwight Oldham, Angel Rodriguez, Amy P. Sing

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Journal of Surgical Oncology
DOIs	https://doi.org/10.1002/jso.24798
State	Accepted/In press - 2017

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1002/jso.24798

Cite this

Bear, H. D., Wan, W., Robidoux, A., Rubin, P., Limentani, S., White, R. L., Granfortuna, J., Hopkins, J. O., Oldham, D., Rodriguez, A., & Sing, A. P. (Accepted/In press). Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923. Journal of Surgical Oncology. https://doi.org/10.1002/jso.24798

Bear, HD, Wan, W, Robidoux, A, Rubin, P, Limentani, S, White, RL, Granfortuna, J, Hopkins, JO, Oldham, D, Rodriguez, A & Sing, AP 2017, 'Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.', Journal of Surgical Oncology. https://doi.org/10.1002/jso.24798

@article{a7b4138a1ef449f098225e3079a9b13d,

title = "Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.",

author = "Bear, {Harry D.} and Wen Wan and Andr{\'e} Robidoux and Peter Rubin and Steven Limentani and White, {Richard L.} and James Granfortuna and Hopkins, {Judith O.} and Dwight Oldham and Angel Rodriguez and Sing, {Amy P.}",

year = "2017",

doi = "10.1002/jso.24798",

language = "English (US)",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley",

}

TY - JOUR

T1 - Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

AU - Bear, Harry D.

AU - Wan, Wen

AU - Robidoux, André

AU - Rubin, Peter

AU - Limentani, Steven

AU - White, Richard L.

AU - Granfortuna, James

AU - Hopkins, Judith O.

AU - Oldham, Dwight

AU - Rodriguez, Angel

AU - Sing, Amy P.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85026368098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026368098&partnerID=8YFLogxK

U2 - 10.1002/jso.24798

DO - 10.1002/jso.24798

M3 - Article

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

ER -

Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this